Glucose does not stimulate apoprotein B secretion from HepG2 cells because of insufficient stimulation of triglyceride synthesis

Journal of Lipid Research

Volumn 39, Issue 11, 1998, Pages 2277-2285

  Jiang, Hongshi ^a   Ginsberg, Henry N ^a   Wu, Xujun ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Apoprotein B; Fatty acids; Glucose; HepG2 cells; Oleic acid; Palmitic acid; Secretion; Triglyceride

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; OLEIC ACID; TRIACYLGLYCEROL;

ARTICLE; BIOAVAILABILITY; CONCENTRATION RESPONSE; FATTY ACID SYNTHESIS; HUMAN; HYPERINSULINEMIA; IMMUNOPRECIPITATION; INCUBATION TIME; ISOTOPE LABELING; LIVER CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM;

APOLIPOPROTEINS B; CARCINOMA, HEPATOCELLULAR; GLUCOSE; HUMANS; LIVER; LIVER NEOPLASMS; OLEIC ACID; TIME FACTORS; TRIGLYCERIDES; TUMOR CELLS, CULTURED;

EID: 0031754372     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Yang, C., S. Chen, S. H. Gianturco, W. A. Bradley, J. T. Sparrow, M. Tanimura, W. Li, D. A. Sparrow, H. DeLoof, M. Rosseneu, F. Lee, Z. Gu, A. M. Gotto, and L. Chan. 1986. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature. 323: 738-742.
2. Knott, T. J., R. J. Pease, L. M. Powell, S. C. Wallis, J. Rall, T. L. Innerarity, B. Blackhart, W. H. Taylor, Y. Marcel, R. Milne, D. Johnson, M. Fuller, A. J. Lusis, B. J. McCarthy, R. W. Mahley, B. Levy-Wilson, and J. Scott. 1986. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature. 323: 734-738.
3. Cladaras, C., M. Hadzopoulou-Cladaras, R. T. Nolte, D. Atkinson, and V. I. Zannis. 1986. The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms. EMBO J. 5: 3495-3507.
4. Dixon, J. L., and H. N. Ginsberg. 1993. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J. Lipid Res. 34: 167-179.
5. Pullinger, C. R., J. D. North, B. Teng, V. A. Rifici, A. E. Ronhild de Brito, and J. Scott. 1989. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J. Lipid Res. 30: 1065-1076.
6. Moberly, J. B., T. G. Cole, D. H. Alpers, and G. Schonfeld. 1990. Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally. Biochim. Biophys. Acta. 1042: 70-80.
7. Dashti, N., D. L. Williams, and P. Alaupovic. 1989. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J. Lipid Res. 30: 1365-1373.
8. Sorci-Thomas, M., M. D. Wilson, F. L. Johnson, D. L. Williams, and L. L. Rude. 1989. Studies on the expression of genes encoding apolipoproteins B-100 and B-48 and the low density lipoprotein receptor in nonhuman primates. J. Biol. Chem. 264: 9039-9045.
9. Kroon, P. A., J. A. DeMartino, G. M. Thompson, and Y. Chao. 1986. Molecular cloning of partial cDNAs for rabbit liver apolipoprotein B and the regulation of its mRNA levels by dietary cholesterol. Proc. Natl. Acad. Sci. USA. 83: 5071-5075.
10. Kushwaha, R. S., C. A. McMahan, G. E. Mott, K. D. Carey, C. A. Reardeon, G. S. Getz, and J. McGill. 1991. Influence of dietary lipids on hepatic mRNA levels of proteins regulating plasma lipoproteins in baboons with high and low levels of large high density lipoproteins. J. Lipid Res. 32: 1929-1940.
11. Leighton, J. K., J. Joyner, J. Zamarripa, M. Deines, and R. A. Davis. 1990. Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. J. Lipid Res. 31: 1663-1668.
12. White, A. L., D. L. Graham, J. LeGros, R. J. Pease, and J. Scott. 1992. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. J. Biol. Chem. 267: 15657-15664.
13. Sato, R., T. Imanaka, A. Takatsuki, and T. Takano. 1990. Degradation of newly synthesized apolipoprotein B-100 in a pre-Golgi compartment. J. Biol. Chem. 265: 11880-11884.
14. Furukawa, S., N. Sakata, H. N. Ginsberg, and J. L. Dixon. 1992. Studies of the sites of intracellular degradation of apolipoprotein B in HepG2 cells. J. Biol. Chem. 267: 22630-22638.
15. Adeli, K. 1994. Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells. J. Biol. Chem. 269: 9166-9175.
16. Yeung, S. J., S. H. Chen, and L. Chan. 1996. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B. Biochemistry. 35: 13843-13848.
17. Wu, X., N. Sakata, K. M. Lele, M. Zhou, and H. N. Ginsberg. 1997. A two-step model for apoB degradation in HepG2 cells. J. Biol. Chem. 272: 11575-11580.
18. Fisher, E., M. Zhou, D. M. Mitchell, X. Wu, S. Omura, H. Wang, A. L. Goldberg, and H. N. Ginsberg. 1997. The degradation of apolipoprotein B-100, an atypical secretory protein, is mediated by a ubiquitin-proteasome pathway that involves heat shock protein 70 and regulation by lipid availability. J. Biol. Chem. 272: 20427-20434.
19. Borén, J., M. Wettesten, A. Sjoberg, T. Thorlin, G. Bondjers, O. Wiklund, and S-O. Olofsson. 1990. The assembly and secretion of apoB-100 containing lipoproteins in HepG2 cells. Evidence for different sites for protein synthesis and lipoprotein assembly. J. Biol. Chem. 265: 10556-10564.
20. Borén, J., L. Graham, M. Wettesten, J. Scott, A. White, and S. Olofsson. 1992. The assembly and secretion of apoB-100-containing lipoproteins in Hep G2 cells. J. Biol. Chem. 267: 9858-9867.
21. Dixon, J. L., S. Furukawa, and H. N. Ginsberg. 1991. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266: 5080-5086.
22. Wu, X., N. Sakata, J. L. Dixon, and H. N. Ginsberg. 1994. Exogenous VLDL stimulates apolipoprotein from HepG2 cells by both pre- and post-translantional mechanisms. J. Lipid Res. 35: 1200-1210.
23. Kurokawa, M., T. Hirano, S. Furukawa, S. Nagano, and M. Adachi. 1995. Similar to oleic acid, eicosapentanoic acid stimulates apolipoprotein B secretion by inhibiting its intracellular degradation in HepG2 cells. Atherosclerosis. 112: 59-68.
24. Wu, X., A. Shang, H. Jiang, and H. N. Ginsberg. 1997. Demonstration of bi-phasic effects of docosahexanoic acid on apoB secretion in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 17: 3347-3355.
25. Wu, X., M. Zhou, L. Huang, J. Wetterau, and H. N. Ginsberg. 1996. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of apoB-containing lipoproteins. J. Biol. Chem. 271: 10277-10281.
26. Cianflone, K. M., Z. Yasruel, M. A. Rodriguez, D. Vas, and A. D. Sniderman. 1990. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J. Lipid Res. 31: 2045-2055.
27. Furukawa, S., and T. Hirano. 1993. Rapid stimulation of apolipoprotein B secretion by oleate is not associated with cholesteryl ester biosynthesis in HepG2 cells. Biochim. Biophys. Acta. 1171: 32-36.
28. Wu, X., N. Sakata, E. Lui, and H. N. Ginsberg. 1994. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J. Biol. Chem. 269: 12375-12382.
29. Musanti, R., L. Giorgini, P. P. Lovisolo, A. Pirillo, A. Chiari, and G. Ghiselli. 1996. Inhibition of acyl-GoA:cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells. J. Lipid Res. 37: 1-14.
30. Graham, A., J. L. Wood, and L. J. Russell. 1996. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells. Biochim. Biophys. Acta. 1302: 46-54.
31. Benoist, F., and T. Grand-Perret. 1996. ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools. Arterioscler. Thromb. Vasc. Biol. 16: 1229-1235.
32. Cianflone, K., S. Dahan, J. C. Monge, and A. D. Sniderman. 1992. Pathogenesis of carbohydrate-induced hypertriglyceridemia using HepG2 cells as a model system. Arterioscler. Thromb. 12: 271-277.
33. Kempen, H. J., A. P. Imbach, T. Giller, W. J. Neumann, U. Hennes, and N. Nakada. 1995. Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors. J. Lipid Res. 36: 1796-1806.
34. Chan, L. 1992. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J. Biol. Chem. 267: 25621-25624.
35. Arad, Y., R. Ramakrishnan, and H. N. Ginsberg. 1990. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. J. Lipid Res. 31: 567-582.
36. Kissebah, A. H., A. Alfarsi, and P. W. Adams. 1981. Integrated regulation for very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism. 20: 856-868.
37. Teng, B., A. D. Sniderman, A. K. Soular, and G. R. Thompson. 1986. Metabolic basis of hyperapobetalipoproteinemia: turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J. Clin. Invest. 77: 663-672.
38. Janus, E. D., A. M. Nicoll, P. R. Turner, P. Magill, and B. Lewis. 1980. Kinetic bases of the primary hyperlipidemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur. J. Clin. Invest. 10: 161-172.
39. Dashti, N. 1992. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. J. Biol. Chem. 267: 7160-7169.
40. Theriault, A., G. Ogbonna, and K. Adeli. 1992. Thyroid hormone modulates apolipoproiein B gene expression in HepG2 cells. Biochem. Biophys. Res. Commun. 186: 617-623.
41. Borchardt, R. A., and R. A. Davis. 1987. Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion. J. Biol. Chem. 262: 16394-16402.
42. Sakata, N., X. Wu, J. L. Dixon, and H. N. Ginsberg. 1993. Proteolysis and lipid-facilitated translocation are distinct but competitive processes which regulate secretion of apolipoprotein B in HepG2 cells. J. Biol. Chem. 268: 22967-22970.
43. Craig, W. Y., R. Nutik, and A. D. Cooper. 1988. Regulation of apoprotein synthesis and secretion in the human hepatoma HepG2. The effect of exogenous lipoprotein. J. Biol. Chem. 263: 13880-13890.
44. Omura, S., H. Tomoda, Q. M. Xu, Y. Takahashi, and Y. Iwai. 1986. Triacsins, new inhibitors of acyl-coA synthetase produced by Streptomyces sp. J. Antibiotics. 39: 1211-1218.
45. Huff, M. W., D. E. Telford, P. H. R. Barrett, D. W. Bilheimer, and P. J. Gillies. 1994. Inhibition of hepatic ACAT decreases apoB secretion in miniature pigs fed a cholesterol-free diet. Arterioscler. Thromb. 14: 1498-1508.
46. Burnett, J. R., L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff. 1997. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Arterioscler. Thromb. Vasc. Biol. 17: 2589-2600.
47. Watts, G. F., R. P. Naoumova, J. M. Kelly, F. M. Riches, K. D. Croft, and G. R. Thompson. 1997. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. Am. J. Physiol. 273: E462-E470.
48. Cuchel, M., E. J. Schaefer, J. S. Millar, P. J. H. Jones, G. G. Dolnikowski, C. Vergani, and A. H. Lichtenstein. 1997. Lovastatin decreases de novo cholesterol synthesis and LDL apoB-100 production rates in combined-hyperlipidemic males. Arterioscler. Thromb. Vasc. Biol. 17: 1910-1917.
49. Melish, J., N. Le, H. Ginsberg, D. Steinberg, and W. V. Brown. 1980. Dissociation of triglyceride and apoprotein-B production in very low density lipoproteins. Am. J. Physiol. 239: E354-E362.
50. Semenkovich, C. F., T. Coleman, and R. Goforth. 1993. Physiologic concentrations of glucose regulate fatty acid synthase activity in HepG2 cells by mediating fatly acid synthase mRNA stability. J. Biol. Chem. 268: 6961-6970.
51. Arrol, S., M. I. Mackness, I. Laing, and P. N. Durrington. 1991. Lipoprotein secretion by the human hepatoma cell line HepG2: differential rates of accumulation of apolipoprotein B and lipoprotein lipids in tissue culture media in response to albumin, glucose and oleate. Biochim. Biophys. Acta. 1086: 72-80.
52. Hellerstein, M. K., M. Christiansen, S. Kaempfer, C. Kletke, K. Wu, J. S. Reid, K. Mulligan, N. S. Hellerstein, and C. H. L. Shackleton. 1991. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J. Clin. Invest. 87: 1841-1852.
53. Aarsland, A., D. Chinkes, and R. R. Wolfe. 1996. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J. Clin. Invest. 98: 2008-2017.
54. Sparks, J. D., and C. E. Sparks. 1990. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J. Biol. Chem. 265: 8854-8862.
55. Sparks, C. E., T. L. Phung, and M. Bolognino. 1996. Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes. Biochem. J. 313: 567-574.
56. Sparks, J. D., and C. E. Sparks. 1994. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim. Biophys. Acta. 1215: 9-32.
57. Lewis, G. F., K. D. Uffelman, L. W. Szeto, and G. Steiner. 1993. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 42: 833-842.
58. Lewis, G. F., K. D. Uffelman, L. W. Szeto, B. Weller, and G. Steiner. 1995. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest. 95: 158-166.
59. Malmstrom, R., C. J. Packard, T. D. Watson, S. Rannikko, M. Caslake, D. Bedford, P. Stewart, H. Yki-Jarvinen, J. Shepherd, and M. R. Taskinen. 1997. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler. Thromb. Vasc. Biol. 17: 1454-1464.
60. Malmstrom, R., C. J. Packard, M. Caslake, D. Bedford, P. Stewart, H. Yki-Jarvinen, J. Shepherd, and M. R. Taskinen. 1998. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes. 47: 779-787.